A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura

[1]  Dan Levy,et al.  Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura , 2010, The Journal of Neuroscience.

[2]  Péter Enyedi,et al.  Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .

[3]  C. Yost,et al.  Regional expression of the anesthetic-activated potassium channel TRESK in the rat nervous system , 2009, Neuroscience Letters.

[4]  Howard S. Smith,et al.  Calcineurin as a nociceptor modulator. , 2009, Pain physician.

[5]  M. Ferrari,et al.  Molecular genetics of migraine , 2009, Human Genetics.

[6]  D. Mendonça,et al.  Familial Clustering of Migraine: Further Evidence From a Portuguese Study , 2009, Headache.

[7]  R. Ofir,et al.  Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9. , 2008, American journal of human genetics.

[8]  Dongyue Huang,et al.  Roles of TRESK, a novel two-pore domain K+ channel, in pain pathway and general anesthesia , 2008, Neuroscience Bulletin.

[9]  T. Licher.  Two-Pore Domain Potassium Channels , 2008 .

[10]  E. Wischmeyer,et al.  TRESK two‐pore‐domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones , 2007, The Journal of physiology.

[11]  H. Lerche,et al.  Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations , 2007, Neurology.

[12]  A. Mathie.  Neuronal two‐pore‐domain potassium channels and their regulation by G protein‐coupled receptors , 2007, The Journal of physiology.

[13]  G. Czirják,et al.  Targeting of Calcineurin to an NFAT-like Docking Site Is Required for the Calcium-dependent Activation of the Background K+ Channel, TRESK* , 2006, Journal of Biological Chemistry.

[14]  T. Strom,et al.  Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine , 2005, The Lancet.

[15]  A. Straube,et al.  Calcineurin Inhibitor‐Induced Headache: Clinical Characteristics and Possible Mechanisms , 2005, Headache.

[16]  C. Hancock.  The long and winding road , 2005, Nature Reviews Drug Discovery.

[17]  R. Lea,et al.  Investigation of hormone receptor genes in migraine , 2005, Neurogenetics.

[18]  Joseph F. Cotten,et al.  Potent Activation of the Human Tandem Pore Domain K Channel TRESK with Clinical Concentrations of Volatile Anesthetics , 2004, Anesthesia and analgesia.

[19]  Z. Tóth,et al.  The Two-pore Domain K+ Channel, TRESK, Is Activated by the Cytoplasmic Calcium Signal through Calcineurin* , 2004, Journal of Biological Chemistry.

[20]  D. Labuda,et al.  Dynamic allele-specific oligonucleotide hybridization on solid support. , 2004, Analytical biochemistry.

[21]  Jes Olesen,et al.  The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.

[22]  S. Cherny,et al.  Significant linkage to migraine with aura on chromosome 11q24. , 2003, Human molecular genetics.

[23]  Kohei Inamura,et al.  A Novel Two-pore Domain K+ Channel, TRESK, Is Localized in the Spinal Cord* , 2003, Journal of Biological Chemistry.

[24]  A. Ballabio,et al.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2 , 2003, Nature Genetics.

[25]  Kelly L Rogers,et al.  Molecular Mechanisms of Migraine , 2003, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[26]  C. Iadecola,et al.  From CSD to headache: A long and winding road , 2002, Nature Medicine.

[27]  Andrew K. Dunn,et al.  Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model , 2002, Nature Medicine.

[28]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[29]  R. Lipton,et al.  Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.

[30]  J. Adelman,et al.  Episodic Ataxia Mutations in Kv1.1 Alter Potassium Channel Function by Dominant Negative Effects or Haploinsufficiency , 1998, The Journal of Neuroscience.

[31]  G. Mitchell,et al.  Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Dennis E Bulman,et al.  Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 , 1996, Cell.

[33]  G. Lambert,et al.  Inhalational Anesthetics Inhibit Spreading Depression: Relevance to Migraine , 1996, Cephalalgia : an international journal of headache.